Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference
10.1038/sj.onc.1210260
Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Bibliography

Jiang, W.-Q., Zhong, Z.-H., Henson, J. D., & Reddel, R. R. (2007). Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene, 26(32), 4635–4647.

Authors 4
  1. W-Q Jiang (first)
  2. Z-H Zhong (additional)
  3. J D Henson (additional)
  4. R R Reddel (additional)
References 65 Referenced 92
  1. Anderson L, Henderson C, Adachi Y . (2001). Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol Cell Biol 21: 1719–1729. (10.1128/MCB.21.5.1719-1729.2001) / Mol Cell Biol by L Anderson (2001)
  2. Blow JJ, Hodgson B . (2002). Replication licensing – defining the proliferative state? Trends Cell Biol 12: 72–78. (10.1016/S0962-8924(01)02203-6) / Trends Cell Biol by JJ Blow (2002)
  3. Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, Mikulits W et al. (2006). Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Cancer Res 66: 3584–3592. (10.1158/0008-5472.CAN-05-2839) / Cancer Res by A Brachner (2006)
  4. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR . (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271–1274. (10.1038/nm1197-1271) / Nat Med by TM Bryan (1997)
  5. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR . (1995). Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240–4248. (10.1002/j.1460-2075.1995.tb00098.x) / EMBO J by TM Bryan (1995)
  6. Cerone MA, Autexier C, Londono-Vallejo JA, Bacchetti S . (2005). A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene 24: 7893–7901. (10.1038/sj.onc.1208934) / Oncogene by MA Cerone (2005)
  7. de Lange T . (2002). Protection of mammalian telomeres. Oncogene 21: 532–540. (10.1038/sj.onc.1205080) / Oncogene by T de Lange (2002)
  8. de Lange T . (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100–2110. (10.1101/gad.1346005) / Genes Dev by T de Lange (2005)
  9. Dunham MA, Neumann AA, Fasching CL, Reddel RR . (2000). Telomere maintenance by recombination in human cells. Nat Genet 26: 447–450. (10.1038/82586) / Nat Genet by MA Dunham (2000)
  10. Fasching CL, Bower K, Reddel RR . (2005). Telomerase-independent telomere length maintenance in the absence of ALT-associated PML bodies. Cancer Res 65: 2722–2729. (10.1158/0008-5472.CAN-04-2881) / Cancer Res by CL Fasching (2005)
  11. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H . (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715. (10.4049/jimmunol.133.4.1710) / J Immunol by J Gerdes (1984)
  12. Gerdes J, Schwab U, Lemke H, Stein H . (1983). Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20. (10.1002/ijc.2910310104) / Int J Cancer by J Gerdes (1983)
  13. Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D et al. (2003). MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421: 952–956. (10.1038/nature01445) / Nature by M Goldberg (2003)
  14. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M et al. (2006). DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8: 416–424. (10.1038/ncb1386) / Nat Cell Biol by S Gonzalo (2006)
  15. Greider CW, Blackburn EH . (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405–413. (10.1016/0092-8674(85)90170-9) / Cell by CW Greider (1985)
  16. Grobelny JV, Godwin AK, Broccoli D . (2000). ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle. J Cell Sci 113: 4577–4585. (10.1242/jcs.113.24.4577) / J Cell Sci by JV Grobelny (2000)
  17. Halpern BC, Clark BR, Hardy DN, Halpern RM, Smith RA . (1974). The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci USA 71: 1133–1136. (10.1073/pnas.71.4.1133) / Proc Natl Acad Sci USA by BC Halpern (1974)
  18. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA et al. (2005). A robust assay for alternative lengthening of telomeres (ALT) in tumors demonstrates the significance of ALT in sarcomas and astrocytomas. Clin Cancer Res 11: 217–225. (10.1158/1078-0432.217.11.1) / Clin Cancer Res by JD Henson (2005)
  19. Houghtaling BR, Cuttonaro L, Chang W, Smith S . (2004). A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol 14: 1621–1631. (10.1016/j.cub.2004.08.052) / Curr Biol by BR Houghtaling (2004)
  20. Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S . (1994). Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA 91: 6098–6102. (10.1073/pnas.91.13.6098) / Proc Natl Acad Sci USA by K Iwabuchi (1994)
  21. Jiang WQ, Zhong ZH, Henson JD, Neumann AA, Chang AC, Reddel RR . (2005). Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of MRE11/RAD50/NBS1 complex. Mol Cell Biol 25: 2708–2721. (10.1128/MCB.25.7.2708-2721.2005) / Mol Cell Biol by WQ Jiang (2005)
  22. Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC, Guarente L . (2001). The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J 20: 905–913. (10.1093/emboj/20.4.905) / EMBO J by FB Johnson (2001)
  23. Judde JG, Ellis M, Frost P . (1989). Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res 49: 4859–4865. / Cancer Res by JG Judde (1989)
  24. Kamei H . (1996). Reversible large-body formation from nuclear bodies upon amino acid(s) starvation in T24 cells. Exp Cell Res 224: 302–311. (10.1006/excr.1996.0140) / Exp Cell Res by H Kamei (1996)
  25. Kamei H . (1997). Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells. Exp Cell Res 237: 207–216. (10.1006/excr.1997.3790) / Exp Cell Res by H Kamei (1997)
  26. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T . (1999). p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321–1325. (10.1126/science.283.5406.1321) / Science by J Karlseder (1999)
  27. Kim SH, Beausejour C, Davalos AR, Kaminker P, Heo SJ, Campisi J . (2004). TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem 279: 43799–43804. (10.1074/jbc.M408650200) / J Biol Chem by SH Kim (2004)
  28. Lei M, Tye BK . (2001). Initiating DNA synthesis: from recruiting to activating the MCM complex. J Cell Sci 114: 1447–1454. (10.1242/jcs.114.8.1447) / J Cell Sci by M Lei (2001)
  29. Li B, de Lange T . (2003). Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell 14: 5060–5068. (10.1091/mbc.e03-06-0403) / Mol Biol Cell by B Li (2003)
  30. Li B, Oestreich S, de Lange T . (2000). Identification of human Rap1: implications for telomere evolution. Cell 101: 471–483. (10.1016/S0092-8674(00)80858-2) / Cell by B Li (2000)
  31. Lu S, Epner DE . (2000). Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 38: 123–130. (10.1207/S15327914NC381_17) / Nutr Cancer by S Lu (2000)
  32. Marciniak RA, Cavazos D, Montellano R, Chen Q, Guarente L, Johnson FB . (2005). A novel telomere structure in human alternative lengthening of telomeres cell line. Cancer Res 65: 2730–2737. (10.1158/0008-5472.CAN-04-2888) / Cancer Res by RA Marciniak (2005)
  33. Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM . (1983). The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117: 429–434. (10.1016/0006-291X(83)91218-4) / Biochem Biophys Res Commun by JO Mecham (1983)
  34. Molenaar C, Wiesmeijer K, Verwoerd NP, Khazen S, Eils R, Tanke HJ et al. (2003). Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J 22: 6631–6641. (10.1093/emboj/cdg633) / EMBO J by C Molenaar (2003)
  35. Moran-Jones K, Wayman L, Kennedy DD, Reddel RR, Sara S, Snee MJ et al. (2005). hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res 33: 486–496. (10.1093/nar/gki203) / Nucleic Acids Res by K Moran-Jones (2005)
  36. Murnane JP, Sabatier L, Marder BA, Morgan WF . (1994). Telomere dynamics in an immortal human cell line. EMBO J 13: 4953–4962. (10.1002/j.1460-2075.1994.tb06822.x) / EMBO J by JP Murnane (1994)
  37. Nabetani A, Yokoyama O, Ishikawa F . (2004). Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J Biol Chem 279: 25849–25857. (10.1074/jbc.M312652200) / J Biol Chem by A Nabetani (2004)
  38. O'Connor MS, Safari A, Liu D, Qin J, Songyang Z . (2004). The human Rap1 protein complex and modulation of telomere length. J Biol Chem 279: 28585–28591. (10.1074/jbc.M312913200) / J Biol Chem by MS O'Connor (2004)
  39. Pavillard V, Drbal AA, Swaine DJ, Phillips RM, Double JA, Nicolaou A . (2004). Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation. Biochem Pharmacol 67: 1587–1599. (10.1016/j.bcp.2004.01.006) / Biochem Pharmacol by V Pavillard (2004)
  40. Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR . (2001). Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 21: 3862–3875. (10.1128/MCB.21.12.3862-3875.2001) / Mol Cell Biol by K Perrem (2001)
  41. Rappold I, Iwabuchi K, Date T, Chen J . (2001). Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol 153: 613–620. (10.1083/jcb.153.3.613) / J Cell Biol by I Rappold (2001)
  42. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang ACM, Moy EL et al. (1995). Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 15: 4745–4753. (10.1128/MCB.15.9.4745) / Mol Cell Biol by EM Rogan (1995)
  43. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD . (2000). p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 151: 1381–1390. (10.1083/jcb.151.7.1381) / J Cell Biol by LB Schultz (2000)
  44. Silverman J, Takai H, Buonomo SB, Eisenhaber F, de Lange T . (2004). Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. Genes Dev 18: 2108–2119. (10.1101/gad.1216004) / Genes Dev by J Silverman (2004)
  45. Smyth CM, Helmer MA, Dalla-Pozza L, Rowe PB . (1993). Flow cytometric DNA analyses of frozen samples from children's solid tumors. Pathology 25: 388–393. (10.3109/00313029309090865) / Pathology by CM Smyth (1993)
  46. Stavropoulos DJ, Bradshaw PS, Li X, Pasic I, Truong K, Ikura M et al. (2002). The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet 11: 3135–3144. (10.1093/hmg/11.25.3135) / Hum Mol Genet by DJ Stavropoulos (2002)
  47. Stern PH, Hoffman RM . (1984). Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 20: 663–670. (10.1007/BF02619617) / In Vitro by PH Stern (1984)
  48. Stern PH, Hoffman RM . (1986). Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 76: 629–639. (10.1093/jnci/76.4.629) / J Natl Cancer Inst by PH Stern (1986)
  49. Takai H, Smogorzewska A, de Lange T . (2003). DNA damage foci at dysfunctional telomeres. Curr Biol 13: 1549–1556. (10.1016/S0960-9822(03)00542-6) / Curr Biol by H Takai (2003)
  50. Tarsounas M, Munoz P, Claas A, Smiraldo PG, Pittman DL, Blasco MA et al. (2004). Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117: 337–347. (10.1016/S0092-8674(04)00337-X) / Cell by M Tarsounas (2004)
  51. Tisdale MJ . (1980). Effect of methionine deprivation on methylation and synthesis of macromolecules. Br J Cancer 42: 121–128. (10.1038/bjc.1980.210) / Br J Cancer by MJ Tisdale (1980)
  52. Toouli CD, Huschtscha LI, Neumann AA, Noble JR, Colgin LM, Hukku B et al. (2002). Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit. Oncogene 21: 128–139. (10.1038/sj.onc.1205014) / Oncogene by CD Toouli (2002)
  53. van Steensel B, de Lange T . (1997). Control of telomere length by the human telomeric protein TRF1. Nature 385: 740–743. (10.1038/385740a0) / Nature by B van Steensel (1997)
  54. van Steensel B, Smogorzewska A, de Lange T . (1998). TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401–413. (10.1016/S0092-8674(00)80932-0) / Cell by B van Steensel (1998)
  55. Wang RC, Smogorzewska A, de Lange T . (2004). Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119: 355–368. (10.1016/j.cell.2004.10.011) / Cell by RC Wang (2004)
  56. Wu G, Jiang X, Lee WH, Chen PL . (2003). Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res 63: 2589–2595. / Cancer Res by G Wu (2003)
  57. Wu G, Lee WH, Chen PL . (2000). NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phrases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J Biol Chem 275: 30618–30622. (10.1074/jbc.C000390200) / J Biol Chem by G Wu (2000)
  58. Xu L, Blackburn EH . (2004). Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules. J Cell Biol 167: 819–830. (10.1083/jcb.200408181) / J Cell Biol by L Xu (2004)
  59. Xu ZX, Timanova-Atanasova A, Zhao RX, Chang KS . (2003). PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol Cell Biol 23: 4247–4256. (10.1128/MCB.23.12.4247-4256.2003) / Mol Cell Biol by ZX Xu (2003)
  60. Yankiwski V, Marciniak RA, Guarente L, Neff NF . (2000). Nuclear structure in normal and Bloom syndrome cells. Proc Natl Acad Sci USA 97: 5214–5219. (10.1073/pnas.090525897) / Proc Natl Acad Sci USA by V Yankiwski (2000)
  61. Ye JZ, de Lange T . (2004). TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nat Genet 36: 618–623. (10.1038/ng1360) / Nat Genet by JZ Ye (2004)
  62. Ye JZ, Donigian JR, Van Overbeek M, Loayza D, Luo Y, Krutchinsky AN et al. (2004). TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem 279: 47264–47271. (10.1074/jbc.M409047200) / J Biol Chem by JZ Ye (2004)
  63. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR . (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59: 4175–4179. / Cancer Res by TR Yeager (1999)
  64. Zhu XD, Kuster B, Mann M, Petrini JH, de Lange T . (2000). Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet 25: 347–352. (10.1038/77139) / Nat Genet by XD Zhu (2000)
  65. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T . (2003). ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 12: 1489–1498. (10.1016/S1097-2765(03)00478-7) / Mol Cell by XD Zhu (2003)
Dates
Type When
Created 18 years, 6 months ago (Feb. 12, 2007, 7:56 a.m.)
Deposited 1 year, 6 months ago (Feb. 10, 2024, 5:35 p.m.)
Indexed 1 month, 1 week ago (July 30, 2025, 11:35 a.m.)
Issued 18 years, 7 months ago (Feb. 5, 2007)
Published 18 years, 7 months ago (Feb. 5, 2007)
Published Online 18 years, 7 months ago (Feb. 5, 2007)
Published Print 18 years, 1 month ago (July 12, 2007)
Funders 0

None

@article{Jiang_2007, title={Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference}, volume={26}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1210260}, DOI={10.1038/sj.onc.1210260}, number={32}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Jiang, W-Q and Zhong, Z-H and Henson, J D and Reddel, R R}, year={2007}, month=feb, pages={4635–4647} }